Portfolio Manager Factsheet

September 2016

Outperformance this month was primarily driven by a recovery in some Japanese equities that had seen recent share price drops. Novo Nordisk underperformed as drug pricing pressure in the U.S. diabetes market continued.  

Read more »

Register for email alerts

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.